Literature DB >> 2278414

Unique features of the self-sustained sequence replication (3SR) reaction in the in vitro amplification of nucleic acids.

T R Gingeras1, K M Whitfield, D Y Kwoh.   

Abstract

The development of a transcription-based amplification system and its application to a retrospective analysis of HIV-1-infected clinical samples demonstrated the specificity and sensitivity of this in vitro amplification procedure. The TAS protocol has been modified to mimic the retroviral strategy of replication, resulting in a self-sustained sequence replication (3SR) amplification reaction which operates under isothermal conditions (37 degrees C). The ability to specifically amplify only RNA sequences in the presence of DNA genomic copies containing the same sequence and the rapid kinetics of the 3SR reaction distinguish it from the well-used PCR protocol.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2278414

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  6 in total

Review 1.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 2.  Advances in nucleic acid-based detection methods.

Authors:  M J Wolcott
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

Review 3.  Application of nucleic acid amplification in clinical microbiology.

Authors:  G Lisby
Journal:  Mol Biotechnol       Date:  1999-08       Impact factor: 2.695

Review 4.  Molecular monitoring of chronic myeloid leukemia: present and future.

Authors:  Cecilia Ching Sze Yeung; Daniel Egan; Jerald P Radich
Journal:  Expert Rev Mol Diagn       Date:  2016-09-06       Impact factor: 5.225

5.  Polymerase chain reaction in the diagnosis of tuberculosis.

Authors:  M Sritharan; V Sritharan
Journal:  Indian J Clin Biochem       Date:  2000-08

Review 6.  Molecular isothermal techniques for combating infectious diseases: towards low-cost point-of-care diagnostics.

Authors:  Hector David de Paz; Pedro Brotons; Carmen Muñoz-Almagro
Journal:  Expert Rev Mol Diagn       Date:  2014-07-23       Impact factor: 5.225

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.